antifungal prophylaxis
Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study
... for antifungal prophylaxis in pa- tients undergoing ...Nonetheless, antifungal prophylaxis remains a topic of some controversy, with no clear consensus among different centers ...
12
Antifungal prophylaxis in chemotherapy associated neutropenia: a retrospective, observational study
... This investigation was a retrospective, observational, cohort study. Non-blinded reviews of patients' electronic files at UCSF, the pharmacy acquisition cost database, and the medical center cost accounting system were ...
7
Single drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review
... of antifungal prophylaxis for the outcomes of colonisation and ...of prophylaxis is reduced with an increased proportion of included surgical ...ble antifungal prophylaxis included ...
16
Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis
... fungal prophylaxis after allogeneic HSCT that has been carried out with a large cohort of pediatric patients under ...of antifungal prophylaxis was good in both groups, since no proven invasive ...
9
Systematic review and mixed treatment comparison meta analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients
... as antifungal prophylaxis in alloHCT recipients post-transplant, a result largely driven by fluconazole’s lack of anti-mould activity; this finding is consistent with a previously published meta- analysis ...
11
Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures
... surgery. Antifungal agents used in the studies were fluconazole 100–400 mg with or without a loading dose and administered orally or intravenously, itraconazole 5 mg/kg orally, and ketoconazole 200 mg orally, and ...
8
Primary antifungal prophylaxis for cryptococcal disease in HIV‐positive people
... primary antifungal prophylaxis with either itraconazole or fluconazole was effective in reducing the incidence of cryptococcal disease in adults with advanced HIV ...tifungal prophylaxis could ...
49
Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage
... POS prophylaxis was administered during only the second year owing to unavail- ability of POS during the first ...systemic antifungal treatment under induc- tion or consolidation ...secondary ...
8
Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation
... oral prophylaxis in pediatric ...for antifungal prophylaxis in children after BMT at the time of this retrospective ...during antifungal mono- prophylaxis in two different posaconazole ...
9
Antifungal Prophylaxis to Prevent Neonatal Candidiasis: A Survey of Perinatal Physician Practices
... use antifungal prophylaxis than those who work in NICUs with little or no ...used prophylaxis regularly may have been more inclined to participate in the ...regarding antifungal ...
10
Prospective Biomarker Screening for Diagnosis of Invasive Aspergillosis in High Risk Pediatric Patients
... ABSTRACT Combined biomarker screening is increasingly used to diagnose invasive aspergillosis (IA) in high-risk patients. In adults, the combination of galactomannan (GM) and fungal DNA detection has proven to be ...
9
Health-care utilization and outcomes of patients at high risk of invasive fungal infection
... for antifungal prophylaxis; however, a large proportion of patients within each cohort (33%–94%) did not receive any antifungal drug during the index ...
17
Changes in the Incidence of Candidiasis in Neonatal Intensive Care Units
... received antifungal prophylaxis. Flucon- azole was the antifungal drug most frequently used for prophylaxis (n = 2625, ...uconazole antifungal prophylaxis beginning in 2002 (Fig ...
9
Predicting invasive fungal disease due to Candida species in non neutropenic, critically ill, adult patients in United Kingdom critical care units
... of antifungal prophylaxis on the risk of developing proven IFD and suggested a reduction in mortality ...of antifungal prophylaxis has only been demonstrated in groups at high risk of IFD and ...
10
Changes in the Incidence of Candidiasis in Neonatal Intensive Care Units
... received antifungal prophylaxis. Flucon- azole was the antifungal drug most frequently used for prophylaxis (n = 2625, ...uconazole antifungal prophylaxis beginning in 2002 (Fig ...
9
Candidemia in critically ill immunocompromised patients: report of a retrospective multicenter cohort study
... of antifungal treatment the day of Candida ...to antifungal therapy or cath- eter removal remained unacceptably long with a median of 3 days, reflecting time to culture ...of antifungal ...
10
Rhizomucor and Scedosporium Infection Post Hematopoietic Stem-Cell Transplant
... that antifungal prophylaxis can also have a selection effect for these IFIs as Rhizomucor ...prophylactic antifungal therapy to posaconazole, according to our service protocol, in ...
7
Tafenoquine and its potential in the treatment and relapse prevention of <em>Plasmodium vivax</em> malaria: the evidence to date
... drug targeting the hepatic stages of primary schizonts and secondary schizonts (hypnozoites) would be critical for causal prophylaxis, terminal prophylaxis/presumptive anti- rela[r] ...
13
Cutting to the Core of the Issue: Emerging Strategies To Reduce Prostate Biopsy Related Infections
... A meta-analysis examining the prevalence of fluoroquinolone- resistant rectal flora in men undergoing transrectal prostate bi- opsy reported the mean rate of colonization with fluoroquin- olone-resistant organisms as ...
5
Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a protocol for a systematic review
... We will use the standard Population, Intervention, Com- parison and Outcome (PICO) approach. The population is defined as infants born at less than 36 weeks. The inter- vention is monoclonal antibody prophylaxis, ...
7